DELZICOL vs ROWASA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Attribute	DELZICOL	ROWASA
Rating	72/100	70/100
Pharmacy pays	~$26.72 /30	~$26.72 /30
Type	RX	RX
Active ingredient	MESALAMINE	MESALAMINE
Manufacturer	Abbvie	Meda Pharms
Dosage forms	Capsule, delayed release	Suspension
Drug class	Aminosalicylate	Aminosalicylate
Boxed warning	None	None
Half-life	about 7 to 9 hours (apparent terminal half-life)	about 7 to 9 hours (apparent terminal half-life)
Treats	Ulcerative Colitis, Proctitis, Sigmoid Diseases	Ulcerative Colitis, Proctitis, Sigmoid Diseases

delzicol rowasa

Rating

72/100

70/100

Pharmacy pays

~$26.72 /30

Type

Active ingredient

MESALAMINE

Manufacturer

Abbvie

Meda Pharms

Dosage forms

Capsule, delayed release

Suspension

Drug class

Aminosalicylate

Boxed warning

None

Half-life

about 7 to 9 hours (apparent terminal half-life)

Treats

Ulcerative Colitis, Proctitis, Sigmoid Diseases

Frequently asked questions

Which is better-rated, Delzicol or Rowasa?

By our independent rating, Delzicol scores higher — 3.6 vs 3.5 out of 5 for Rowasa. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Delzicol or Rowasa?

Pharmacies pay about the same to acquire either one — roughly $26.72 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Delzicol and Rowasa?

Both Delzicol and Rowasa share the active ingredient Mesalamine.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.